ArticleRevista medica del Instituto Mexicano del Seguro Social2026
[Myelopathy secondary to thoracic actinomycetoma].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mycetoma is a chronic subcutaneous infection caused by fungi (eumycetoma) or filamentous bacteria (actinomycetoma), acquired through traumatic inoculation. It affects the skin, subcutaneous tissue, and in advanced cases, deeper structures such as bones or the spinal cord. Its presentation can lead to severe complications, including paraplegia. Clinical case: 74-year-old male farmer hospitalized due to sudden-onset paraplegia, with inability to walk and urinary and fecal incontinence. A dermatology consult was requested for a dermatosis affecting the trunk, located on the posterior aspect of the left hemithorax, which was localized and asymmetrical. The lesion consisted of multiple fistulas discharging purulent secretion and numerous erythematous-violaceous atrophic scars that coalesced to form a plaque measuring 30 x 30 cm. Neurologically, a complete spinal cord syndrome was diagnosed. Microbiological studies revealed the presence of grains measuring between 50 and 100 μm composed of filamentous bacteria, positive for periodic acid-Schiff (PAS) stain and acid-fast with Ziehl-Neelsen staining, consistent with Nocardia spp. Magnetic resonance imaging showed involvement of vertebrae T6, T7, and T8. Conclusions: Actinomycetoma is endemic in Mexico. The classic triad includes a subcutaneous mass, fistulas, and grains. Its progression can cause vertebral destruction and myelopathy. Magnetic resonance imaging is the diagnostic study of choice due to its high soft tissue resolution. Therapeutic management combines antibiotics with activity against actinomycetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.